Latest Breaking News On - Harpoon therapeutics - Page 1 : comparemela.com

Zentalis Pharmaceuticals (ZNTL) Appoints Luke Walker to its Board

Zentalis Pharmaceuticals (ZNTL) Appoints Luke Walker to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Kimberly blackwellLuke walkerClinical development at seagenProvidence regional medical centerMerck co incUniversity of oklahoma health sciences centerPharmaceuticals incChief medical officerHarpoon therapeuticsChief executiveVice presidentClinical developmentSpecial distinctionOklahoma health sciencesZentalis board

Viking, CRISPR, Cytokinetics are M&A targets: Wells Fargo

Viking, CRISPR, Cytokinetics are M&A targets: Wells Fargo
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Moonlake immunotherapeuticsArcutis biotherapeuticsZealand pharmaVerona pharmaBridgebio pharmaMohit bansalNeurocrine biosciencesIovance biotherapeuticsWells fargoAlnylam pharmaceuticalsRhythm pharmaceuticalsApellis pharmaceuticalsArrowhead pharmaceuticalsAmicus therapeuticsXenon pharmaceuticalsMadrigal pharmaceuticals

Amgen Drug Wins US Approval for Advanced Small Cell Lung Cancer

Amgen Drug Wins US Approval for Advanced Small Cell Lung Cancer
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.

United statesBoehringer ingelheim gmbAstrazeneca imfinziJay bradnerRobert langrethBloomberg amgen incHarpoon therapeutics incMerck coDrug administrationNew england journalHarpoon therapeuticsBoehringer ingelheim gmbh

Amgen Drug Wins US Approval for Type of Advanced Lung Cancer

Amgen Inc. won US approval for a new drug to treat a particularly aggressive form of advanced lung cancer, providing a badly needed new option for patients when chemotherapy stops working.

United statesBoehringer ingelheim gmbAstrazeneca imfinziRobert langrethJay bradnerDrug administrationMerck coHarpoon therapeutics incNew england journalHarpoon therapeuticsBoehringer ingelheim gmbh

Viracta Therapeutics Appoints Michael Faerm as Chief Financial Officer

Viracta Therapeutics Appoints Michael Faerm as Chief Financial Officer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Ashleigh barretoMichael faermMark rotheraTheravance incViracta therapeutics incStanford universityRegeneron pharmaceuticalsHarvard business schoolHarpoon therapeutics incArtiva biotherapeutics incMerrill lynchHead of investor relations corporate communicationsColumbia universityCredit suisseInnoviva incTherapeutics appoints michael faerm